Cipla Ltd, an Indian Pharma giant has scaled up the production of Covid-19 medication Remdesivir, it announced on Tuesday.
In a statement to Reuters, the company said, “We have scaled up the production of Remdesivir by 2 times from the last wave of the pandemic. Given the unprecedented demand for the drug, we have now further ramped up our capacities through our network.”
Cipla is working with authorities to restrict Remdesivir supply just to hospitals and places with a high burden of severe COVID-19 cases, it added.
